EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Prospective Observational Study of N-terminal Pro–Brain Natriuretic Peptide Levels in Obese and Nonobese Women during Pregnancy

Anna E Denoble iD, Julia M Moyett, Sarah A Goldstein, Cary C Ward, Tracy Truong, Alaattin Erkanli, Andra H James, Chad A Grotegut

American Journal of Perinatology · 01.04.2023 · 40 (05) · 467-474

DOI: 10.1055/a-1925-1532 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.04.2023. Verfasst von Anna E Denoble und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Health System, Durham, North Carolina. Hauptthemen laut MEDLINE: Obesity, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Duke Department of Obstetrics and Gynecology Hammond Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

N-terminal pro–brain natriuretic peptide (NT-proBNP), a marker of ventricular dysfunction, varies by body mass index (BMI) outside of pregnancy. This study aimed to determine whether obesity affects NT-proBNP levels in pregnancy. Study Design This was a prospective observational study of healthy pregnant people in the third trimester (3TM) and postpartum (PP). Patients were excluded if they had significant medical comorbidities or if their fetuses had anomalies, growth restriction or aneuploidy. NT-proBNP was measured at 28 weeks (3TM), predelivery (PD), 1 to 2 days PP (immediate postpartum [IPP]), and 4 to 6 weeks PP (delayed postpartum [DPP]). LogNT-proBNP levels were analyzed using linear mixed effects models, including BMI < or ≥30, time, and time-by-BMI interactions.

Results

Fifty-five people (28 [51%] with BMI ≥ 30 and 27 [49%] with BMI < 30) were enrolled. A greater proportion of obese than nonobese subjects developed hypertensive disorders of pregnancy (50 vs. 15%, p = 0.010) and obese patients had higher systolic blood pressures at all time points (p < 0.05). NT-proBNP levels (median [interquartile range] in pg/mL) were 18 (6–28) versus 26 (17–48) at 3TM, 16 (3–38) versus 43 (21–60) at PD, 58 (20–102) versus 63 (38–155) at IPP, and 33 (27–56) versus 23 (8–42) at DPP for obese compared with nonobese patients. In linear mixed effects models, logNT-proBNP was lower in obese patients at 3TM (β = −0.89 [95% confidence interval, CI: −1.51, −0.26]) and PD (β = −1.05 [95% CI: −1.72, −0.38]). The logNT-proBNP trends over time differed by BMI category, with higher values in obese patients at both PP time points compared with the 3TM (IPP β = 1.24 [95% CI: 0.75, 1.73]; DPP β = 1.08 [95% CI: 0.52, 1.63]), but only IPP for nonobese patients (β = 0.87 [95% CI: 0.36, 1.38]).

Conclusion

Obese patients had lower NT-proBNP levels than nonobese patients during pregnancy but not PP. The prolonged PP elevation in NT-proBNP in obese patients suggests that their PP cardiac recovery may be more prolonged. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityNatriuretic Peptide, BrainPregnancyHumansFemalePeptide FragmentsComorbidityBiomarkers

Substanzen

pro-brain natriuretic peptide (1-76)Natriuretic Peptide, BrainPeptide FragmentsBiomarkers

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Health System, Durham, North Carolina.
  • Duke University School of Medicine, Duke University, Durham, North Carolina.
  • Division of Cardiology, Department of Medicine, Duke University Health System, Durham, North Carolina.
  • Department of Biostatistics and Bioinformatics, Duke University Health System, Durham, North Carolina.
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Wake Forest Baptist Health System, Winston-Salem, North Carolina.

ORCID-Profile: Anna E Denoble

Förderung

  • NCATS NIH HHS
  • Duke Department of Obstetrics and Gynecology Hammond Research Fund

Zitieren

APA

Denoble, A. E., Moyett, J. M., Goldstein, S. A., Ward, C. C., Truong, T., Erkanli, A., James, A. H., & Grotegut, C. A. (2023). Prospective Observational Study of N-terminal Pro–Brain Natriuretic Peptide Levels in Obese and Nonobese Women during Pregnancy. American Journal of Perinatology, 40(05), 467-474. https://doi.org/10.1055/a-1925-1532

Vancouver

Denoble AE, Moyett JM, Goldstein SA, Ward CC, Truong T, Erkanli A, et al. Prospective Observational Study of N-terminal Pro–Brain Natriuretic Peptide Levels in Obese and Nonobese Women during Pregnancy. American Journal of Perinatology. 2023;40(05):467-474. doi:10.1055/a-1925-1532

BibTeX
@article{Denoble2023,
  author = {Denoble, Anna E and Moyett, Julia M and Goldstein, Sarah A and Ward, Cary C and Truong, Tracy and Erkanli, Alaattin and James, Andra H and Grotegut, Chad A},
  title = {Prospective Observational Study of N-terminal Pro–Brain Natriuretic Peptide Levels in Obese and Nonobese Women during Pregnancy},
  journal = {American Journal of Perinatology},
  year = {2023},
  volume = {40},
  number = {05},
  pages = {467--474},
  doi = {10.1055/a-1925-1532}
}
Kostenlos starten →